et al. Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals and in humans. Proc. Natl. Acad. Sci. USA
95, 708–713 (1998).
Measurement of T-cell kinetics: recent methodologic advances. Immunol. Today
20, 438–441 (1999).
Busch, R., Neese, R.A., Awada, M., Hayes, G.M. & Hellerstein, M.K.
Measurement of cell proliferation by heavy water labeling. Nat. Protoc.
2, 3045–3057 (2007).
et al. Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc. Natl. Acad. Sci. USA
99, 15345–15350 (2002).
et al. Measurement and modeling of human T cell kinetics. Eur. J. Immunol.
33, 2316–2326 (2003).
Asquith, B., Debacq, C., Macallan, D.C., Willems, L. & Bangham, C.
Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol.
23, 596–601 (2002).
Tough, D.F. & Sprent, J.
Turnover of naive- and memory-phenotype T cells. J. Exp. Med.
179, 1127–1135 (1994).
et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J. Exp. Med.
194, 1731–1741 (2001).
Schwarting, R., Gerdes, J., Niehus, J., Jaeschke, L. & Stein, H.
Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J. Immunol. Methods
90, 65–70 (1986).
Quah, B.J., Warren, H.S. & Parish, C.R.
Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat. Protoc.
2, 2049–2056 (2007).
et al. Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. Nat. Protoc.
2, 2057–2067 (2007).
Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods
243, 147–154 (2000).
Michie, C.A., McLean, A., Alcock, C. & Beverley, P.C.
Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature
360, 264–265 (1992).
et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature
373, 123–126 (1995).
Wolfe, R.R. & Chinkes, D.L.
Calculation of substrate kinetics: single pool model. in Isotope Tracers in Metabolic Research (eds. Wolfe, R.R. & Chinkes, D.L.) 21–50 (John Wiley & Sons, Hoboken, New Jersey, 2005).
et al. Central memory CD8(+) T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression. J. Immunol.
180, 7907–7918 (2008).
et al. Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool. Proc. Natl. Acad. Sci. USA
105, 6115–6120 (2008).
et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo
. J. Clin. Invest.
116, 2423–2433 (2006).
et al. Rapid turnover of T cells in acute infectious mononucleosis. Eur. J. Immunol.
33, 2655–2665 (2003).
et al. Rapid turnover of effector-memory CD4(+) T cells in healthy humans. J. Exp. Med.
200, 255–260 (2004).
et al. Direct measurement of T cell subset kinetics in vivo in elderly men and women. J. Immunol.
173, 1787–1794 (2004).
et al. B cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood
105, 3633–3640 (2005).
et al. Reduction of B cell turnover in chronic lymphocytic leukaemia. Br. J. Haematol.
143, 240–247 (2008).
et al. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med.
5, 83–89 (1999).
et al. Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J. Clin. Invest.
112, 956–966 (2003).
et al. Factors influencing T-cell turnover in HIV-1-seropositive patients. J. Clin. Invest.
105, R1–R8 (2000).
et al. Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients. J. Clin. Invest.
115, 2139–2148 (2005).
et al. CD4 T cell survival after intermittent Interleukin-2 therapy is predictive of an Increase in the CD4 T cell count of HIV-infected patients. J. Infect. Dis.
198, 843–850 (2008).
et al. Measuring lymphocyte kinetics in tropical field settings. Trans. R. Soc. Trop. Med. Hyg.
99, 675–685 (2005).
et al. Long-term effects of perinatal nutrition on T lymphocyte kinetics in young Gambian men. Am. J. Clin. Nutr.
85, 480–487 (2007).
Interactions between deoxyribonucleotide and DNA synthesis. Annu. Rev. Biochem.
57, 349–374 (1988).
Cohen, A., Barankiewicz, J., Lederman, H.M. & Gelfand, E.W.
Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J. Biol. Chem.
258, 12334–12340 (1983).
et al. General immunologic evaluation of patients with human immunodeficiency virus infection. in Manual of Molecular and Clinical Laboratory Immunology (eds. Detrick, B., Hamilton, R.G. & Folds, J.D.) 848–861 (ASM Press, Washington DC, 2006).
Lawrence, C.W. & Braciale, T.J.
Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J. Immunol.
173, 1209–1218 (2004).
et al. Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J. Exp. Med.
204, 2171–2185 (2007).
et al. Measuring the diaspora for virus-specific CD8+ T cells. Proc. Natl. Acad. Sci. USA
98, 6313–6318 (2001).
et al. Unique ability of activated CD4+ T cells but not rested effectors to migrate to non-lymphoid sites in the absence of inflammation. J. Biol. Chem.
282, 6106–6115 (2007).
Marzo, A.L., Yagita, H. & Lefrancois, L.
Cutting edge: migration to nonlymphoid tissues results in functional conversion of central to effector memory CD8 T cells. J. Immunol.
179, 36–40 (2007).
Berhanu, D., Mortari, F., De Rosa, S.C. & Roederer, M.
Optimized lymphocyte isolation methods for analysis of chemokine receptor expression. J. Immunol. Methods
279, 199–207 (2003).
Hodge, T.W., Sasso, D.R. & McDougal, J.S.
Humans with OKT4-epitope deficiency have a single nucleotide base change in the CD4 gene, resulting in substitution of TRP240 for ARG240. Hum. Immunol.
30, 99–104 (1991).
Tchilian, E.Z. & Beverley, P.C.
Altered CD45 expression and disease. Trends Immunol.
27, 146–153 (2006).
et al. Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation. Anal. Biochem.
298, 189–195 (2001).
et al. A comparison of microLC/electrospray ionization-MS and GC/MS for the measurement of stable isotope enrichment from a [2H2]-glucose metabolic probe in T-cell genomic DNA. Anal. Chem.
75, 6517–6522 (2003).
et al. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc. Natl. Acad. Sci. USA
104, 8035–8040 (2007).
Borghans, J.A. & De Boer, R.J.
Quantification of T-cell dynamics: from telomeres to DNA labeling. Immunol. Rev.
216, 35–47 (2007).
HIV tropism and CD4+ T-cell depletion. Nat. Med.
8, 537–538 (2002).
Ribeiro, R.M., Mohri, H., Ho, D.D. & Perelson, A.S.
In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?
Proc. Natl. Acad. Sci. USA
99, 15572–15577 (2002).
et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med.
194, 1277–1287 (2001).
et al. Naive T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion. J. Virol.
80, 2665–2674 (2006).
et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology
121, 258–265 (2007).
et al. CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion. J. Leukoc. Biol.
72, 271–278 (2002).